Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,533Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Bayer Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Sorafenib

Brand Name : NEXAVAR

Patent Number : 2315646

Filing Date : 1998-12-22

Strength per Unit : 200 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-12-22

Date Granted : 2010-02-09

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Sorafenib

Brand Name : NEXAVAR

Patent Number : 2359510

Filing Date : 2000-01-12

Strength per Unit : 200 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-01-12

Date Granted : 2007-02-13

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Sorafenib

Brand Name : NEXAVAR

Patent Number : 2581843

Filing Date : 2005-09-20

Strength per Unit : 200 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-09-20

Date Granted : 2012-05-15

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Sorafenib

Brand Name : NEXAVAR

Patent Number : 2526636

Filing Date : 2004-05-19

Strength per Unit : 200 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-05-19

Date Granted : 2017-09-05

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Sorafenib

Brand Name : NEXAVAR

Patent Number : 2315715

Filing Date : 1998-12-22

Strength per Unit : 200 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-12-22

Date Granted : 2010-06-22

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Sorafenib

Brand Name : NEXAVAR

Patent Number : 2601955

Filing Date : 2006-02-22

Strength per Unit : 200 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-02-22

Date Granted : 2012-07-10

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Sorafenib

Brand Name : NEXAVAR

Patent Number : 2359244

Filing Date : 2000-01-13

Strength per Unit : 200 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-01-13

Date Granted : 2013-10-08

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Sorafenib

Brand Name : NEXAVAR

Patent Number : 2526617

Filing Date : 2004-05-19

Strength per Unit : 200 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2024-05-19

Date Granted : 2015-04-28

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Sorafenib

Brand Name : NEXAVAR

Patent Number : 2475703

Filing Date : 2003-02-11

Strength per Unit : 200 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-02-11

Date Granted : 2016-12-20

blank